The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

4 months ago

Version History

Version 44 months ago

What changed: Added Wedbush analyst expectations regarding IBM's AI and hybrid cloud momentum, specific earnings release timing, and focus on WatsonX and Red Hat platforms.

Version 34 months ago

What changed: The story was updated to include expectations for the upcoming week, including the release of U.S. PMI data and the shift in focus toward airline sector earnings.

Version 24 months ago

What changed: Added Oppenheimer analysts' sentiment regarding IBM's potential to raise its full-year 2026 revenue guidance.

Version 14 months ago

What changed: Updated the story to highlight Merck (MRK) as a primary candidate for a significant earnings beat, adding specific data on its ROIC and valuation discrepancy.

StocksMediumUpdated×4•Originally published 15 April 2026•Updated 17 April 2026•

1 min read

Alphabet and IBM Among Major Firms Poised to Beat Quarterly Earnings Estimates

Key Facts

1Major companies including Alphabet and IBM show positive indicators for potential earnings beats in their upcoming reports.

2Projections are based on a combination of historical earnings surprise track records and the Zacks earnings ESP model.

Analytical reports indicate that major firms, led by Alphabet and IBM, are positioned to exceed quarterly earnings expectations. Wedbush anticipates solid IBM performance driven by accelerated demand in AI and hybrid cloud services, with the company scheduled to report its fiscal first-quarter 2026 results next Wednesday. Analysts highlight the WatsonX and Red Hat platforms as key growth drivers being closely monitored by investors. Meanwhile, Merck (MRK) remains a high-conviction candidate for an earnings beat, with Street EPS estimates reportedly understated by $3.29 per share. Market focus is also shifting toward upcoming flash U.S. services and manufacturing PMI readings for April. These developments are expected to bolster investor confidence in corporate financial health and institutional spending strength.

Sources:

zacks.com